Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $632K 9,803 sh |
| Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $75K 10.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $807K 12.1K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 16 | Ditillo DavidChief Information Officer | Open-market sale · 10b5-1 plan | SELL | $422K 12.4K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 16 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $406K 6,006 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $807K 7,764 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 15 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $2.37M 18.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 15 | Buonasera DavidCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $22K 871 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 261 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 352 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 352 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $49K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 526 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,262 154 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $202K 3,096 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,262 154 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 352 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $22K 353 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,201 153 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 261 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $9,201 153 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 525 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 224 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 525 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $21K 3,000 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 223 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $32K 526 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $154K 2,430 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 262 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $74K 1,200 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 223 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $14K 223 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 13 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $16K 262 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 11 | Flammer Martina M.D.Chief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $1.13M 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 11 | Feierstein Matthew DavidPresident | Open-market sale · 10b5-1 plan | SELL | $51K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 10 | O'Brien Michael GrahamCFO | Open-market sale · 10b5-1 plan | SELL | $20K 5,000 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 10 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | Open-market sale · 10b5-1 plan | SELL | $34K 500 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $170K 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Tabak ShawnCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $405K 25.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 8 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $273K 9,292 sh | Aug 7, 2026 traded Aug 6, 2026 |